Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Daiichi Sankyo Europe GmbH

2 abstracts

Abstract
Intracranial efficacy of datopotamab deruxtecan (Dato-DXd) in patients (pts) with previously treated advanced/metastatic non-small cell lung cancer (a/m NSCLC) with actionable genomic alterations (AGA): Results from TROPION-Lung05.
Org: University Hospital of Nantes, Daiichi Sankyo Europe GmbH, Department of Medical Oncology, Thoracic Group,
Abstract
Development of a quantitative systems pharmacology (QSP) model to support dose optimization of DS-1103a (anti SIRPa antibody) in combination with trastuzumab deruxtecan in patients with cancer.
Org: Daiichi Sankyo Inc., Certara Germany GmbH, Daiichi Sankyo Shinagawa R&D Center, Daiichi Sankyo Europe GmbH,